Sort
48,018 grants matching “immunotherapy”
Functions of Transmembrane and Soluble Fas ligand
$440,287Boston University Medical Campus · R01 · FY2002 · CA
Computer aided diagnosis of cancer metastases in the brain
$440,259Xiaoyin Xu · Brigham And Women'S Hospital · R01 · FY2017 · LM
Probing cellular, molecular and biomechanical barriers to immunotherapy in the tumor microenvironment with organotypic in vitro models of the tumor-lympho-immune interface
$440,245Melody A Swartz · University Of Chicago · R01 · FY2025 · CA
Neoadjuvant immunotherapy approaches to early stage melanoma
$440,235Meenhard Herlyn · Wistar Institute · P50 · FY2022 · CA
BAFF-DRIVEN TARGETED IMMUNOTHERAPY FOR PATIENTS WITH LEUKEMIA
$440,220University Of North Carolina At Chapel Hill · · FY2011 · Department of Defense
FUNCTIONAL ANALYSIS OF PATHOGENIC AND PROTECTIVE PEANUT ALLERGEN-SPECIFIC HUMAN ANTIBODIES
$440,214Scott Dexter Boyd · Stanford University · R01 · FY2018 · AI
Dermal Lymphatic Transport and Cutaneous Immune Balance
$440,210Amanda W. Lund · New York University School Of Medicine · R01 · FY2022 · AR
Dermal Lymphatic Transport and Cutaneous Immune Balance
$440,210Amanda W. Lund · New York University School Of Medicine · R01 · FY2023 · AR
Optimizing pre-analytical variables for reliable mass spectrometry-based quantification of immunomodulatory proteins in cerebrospinal fluid in pediatric neuro-oncology trials
$440,171Amanda G Paulovich · Fred Hutchinson Cancer Center · U01 · FY2025 · CA
Multiscale analysis of metabolic inflammation as a driver of breast cancer
$440,153Gerald V Denis · Boston University Medical Campus · U01 · FY2024 · CA
Focal segmental glomerulosclerosis: Treatment
$440,068Jeffrey Burnett Kopp · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2009 · DK
Surrogate imaging biomarkers for tracking anti-stromal therapy
$440,024Marvin M Doyley · University Of Rochester · R56 · FY2017 · EB
Improving Glioma Immunotherapy Efficacy by Regulating Tumor Inflammation
$440,000Behnam Badie · Beckman Research Institute/City Of Hope · R01 · FY2023 · NS
A new deep learning approach to probe the molecular basis of inhalation allergens
$440,000Werner A Braun · University Of Texas Med Br Galveston · R21 · FY2025 · AI
The role of miR-142 in regulatory T cell Development and function
$440,000Mark P Boldin · Beckman Research Institute/City Of Hope · R01 · FY2023 · AI
The role of miR-142 in regulatory T cell Development and function
$440,000Mark P Boldin · Beckman Research Institute/City Of Hope · R01 · FY2022 · AI
The role of miR-142 in regulatory T cell Development and function
$440,000Mark P Boldin · Beckman Research Institute/City Of Hope · R01 · FY2021 · AI
The role of miR-142 in regulatory T cell Development and function
$440,000Mark P Boldin · Beckman Research Institute/City Of Hope · R01 · FY2020 · AI
Proteogenomic Studies aimed at understanding ovarian tumor responses to agents targeting the DNA damage response and translating this knowledge into clinical benefit
$440,000Amanda G Paulovich · Fred Hutchinson Cancer Research Center · U01 · FY2020 · CA
The role of miR-142 in regulatory T cell Development and function
$440,000Mark P Boldin · Beckman Research Institute/City Of Hope · R01 · FY2024 · AI
Creation of a transgenic pig model permissive to HBV infection
$440,000Robert Layne Kruse · University Of Texas Med Br Galveston · R21 · FY2025 · AI
Regulation of CD8+T cells by Zbtb42
$439,956Venuprasad K Poojary · Ut Southwestern Medical Center · R01 · FY2022 · CA
Expression of recombinant Fc receptors by engineered NK cells to enhance cancer cell killing
$439,940Bruce K Walcheck · University Of Minnesota · R01 · FY2021 · CA
(PQ10) Enhancing responses to immune checkpoint blockade in melanoma via modulation of the microbiome
$439,919Jennifer A. Wargo · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
CLINICAL THERAPY TRIALS
$439,902Katherine Kurshan Matthay · Children'S Hospital Of Los Angeles · P01 · FY2010 · CA